Neutral and cationic half‐sandwich arene d6 metal complexes containing pyridyl and pyrimidyl thiourea ligands with interesting bonding modes: Synthesis,structural and anti‐cancer studies

The reaction of [(p‐cymene)RuCl₂]₂ and [Cp*MCl₂]₂ (M = Rh/Ir) with benzoyl (2‐pyrimidyl) thiourea (L1) and benzoyl (4‐picolyl) thiourea (L2) led to the formation of cationic complexes bearing formula [(arene) M (L1)к² _(N,S) Cl]⁺ and [(arene) M (L2)к²_(N,S)Cl]⁺ [(arene) = p‐cymene, M = Ru, ( 1 , 4 ); Cp*, M = Rh ( 2 , 5 ) and Ir ( 3 , 6 )]. Precursor compounds reacted with benzoyl (6‐picolyl) thiourea (L3) affording neutral complexes having formula [(arene) M (L3)к¹_(S)Cl₂] [arene = p‐cymene, M = Ru, ( 7 ); Cp*, M = Rh ( 8 ), Ir ( 9 )]. X‐ray studies revealed that the methyl substituent attached to the pyridine ring in ligands L2 and L3 affects its coordination mode. When methyl group is at the para position of the pyridine ring (L2), the ligand coordinated metal in a bidentate chelating N, S‐ mode whereas methyl group at ortho position (L3), it coordinated in a monodentate mode. Further the anti‐cancer studies of the thiourea derivatives and its complexes carried out against HCT‐116, HT‐29 (human colorectal cancer), Mia‐PaCa‐2 (human pancreatic cancer) and ARPE‐19 (non‐cancer retinal epithelium) cell lines showed that the thiourea ligands are inactive but upon complexation, the metal compounds displayed potent and selective activity against cancer cells in vitro. Iridium complexes were found to be more potent as compared to ruthenium and rhodium complexes.     

Synthesis,structural and chemosensitivity studies of arene d6 metal complexes having N‐phenyl‐N´‐(pyridyl/pyrimidyl)thiourea derivatives

The d⁶ metal complexes of thiourea derivatives were synthesized to investigate its cytotoxicity. Treatment of various N‐phenyl‐N´ pyridyl/pyrimidyl thiourea ligands with half‐sandwich d⁶ metal precursors yielded a series of cationic complexes. Reactions of ligand (L1‐L3) with [(p‐cymene)RuCl₂]₂ and [Cp*MCl₂]₂ (M = Rh/Ir) led to the formation of a series of cationic complexes bearing general formula [(arene)M(L1)к²_(N,S)Cl]⁺, [(arene)M(L2)к²_(N,S)Cl]⁺ and [(arene)M(L3)к²_(N,S)Cl]⁺ [arene = p‐cymene, M = Ru ( 1 , 4 , 7 ); Cp*, M = Rh ( 2 , 5 , 8 ); Cp*, Ir ( 3 , 6 , 9 )]. These compounds were isolated as their chloride salts. X‐ray crystallographic studies of the complexes revealed the coordination of the ligands to the metal in a bidentate chelating N,S‐ manner. Further the cytotoxicity studies of the thiourea derivatives and its complexes evaluated against HCT‐116 (human colorectal cancer), MIA‐PaCa‐2 (human pancreatic cancer) and ARPE‐19 (non‐cancer retinal epithelium) cancer cell lines showed that the thiourea ligands displayed no activity. Upon complexation however, the metal compounds possesses cytotoxicity and whilst potency is less than cisplatin, several complexes exhibited greater selectivity for HCT‐116 or MIA‐PaCa‐2 cells compared to ARPE‐19 cells than cisplatin in vitro. Rhodium complexes of thiourea derivatives were found to be more potent as compared to ruthenium and iridium complexes.     

Synthesis,antimicrobial activity and molecular docking of di‐ and triorganotin (IV) complexes with thiosemicarbazide derivatives

Six organotin (IV) complexes with two ligands derived from 2,3‐butanedione and thiosemicarbazide have been synthesized and fully characterized by several spectroscopic techniques, including ¹¹⁹Sn NMR and single crystal X‐ray diffraction. Reactions of the ligand diacetyl‐2‐(thiosemicarbazone)‐3‐(3‐hydroxy‐2‐naphthohydrazone), L¹H₂, with SnR₂Cl₂ (R = Me, Bu, Ph) lead to the obtaining of complexes 1 – 3 with general formula [SnR₂L¹] (R = Me 1 , R = Bu 2 , R = Ph 3 ), in which the ligand is doubly deprotonated and behaves as a N₂SO donor, whereas from the reactions of diacetyl‐2‐thiosemicarbazone, HATs, with the same organotin precursors any complex could be isolated. By contrast, reaction of HATs with SnR₃Cl induces the ligand cyclization to form a 1,2,4‐triazine‐3‐thione that binds to the metal as a monoanionic donor in a mono or bidentate manner to form compounds 4 – 6 with formula [SnR₃L²] (R = Me 4 , R = Bu 5 , R = Ph 6 ). The antimicrobial activity of the ligands and the six complexes was tested towards bacteria and fungi, including clinical isolated strains. The results show that the ligands are devoid of activity, except HATs that displays activity against Bacillus subtilis. Conversely, the complexes exhibit good antimicrobial properties against Gram positive and negative bacteria, yeasts and moulds. The best results are obtained for complexes [SnBu₃L²] 5 and [SnPh₃L²] 6 , indicating that their more lipophilic nature could play an important role in the ease of microbial cell penetration. In some cases, these complexes display similar or higher activity than that of ampicillin and miconazole, used as antibacterial and antifungal positive controls, respectively. Docking study with DHPS protein (S. aureus) has shown that out of six drugs, the compound 6 has the best binding affinity (?8.5 Kcal/mol).     

In‐ and Out‐of‐Cavity Interactions by Modulating the Size of Ruthenium Metallarectangles

Cationic (arene)ruthenium‐based tetranuclear complexes of the general formula [Ru₄(η⁶‐p‐cymene)₄(μ‐N∩N)₂(μ‐OO∩OO)₂]⁴⁺ were obtained from the dinuclear (arene)ruthenium complexes [Ru₂(η⁶‐p‐cymene)₂(μ‐OO∩OO)₂Cl₂] (p‐cymene=1‐methyl‐4‐(1‐methylethyl)benzene, OO∩OO=5,8‐dihydroxy‐1,4‐naphthoquinonato(2?), 9,10‐dihydroxy‐1,4‐anthraquinonato(2?), or 6,11‐dihydroxynaphthacene‐5,12‐dionato(2?)) by reaction with pyrazine or bipyridine linkers (N∩N=pyrazine, 4,4′‐bipyridine, 4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine]) in the presence of silver trifluoromethanesulfonate (CF₃SO₃Ag) (Scheme). All complexes 4 – 12 were isolated in good yield as CF₃SO salts, and characterized by NMR and IR spectroscopy. The host–guest properties of the metallarectangles incorporating 4,4′‐bipyridine and (4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine] linkers were studied in solution by means of multiple NMR experiments (1D, ROESY, and DOSY). The largest metallarectangles 10 – 12 incorporating (4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine] linkers are able to host an anthracene, pyrene, perylene, or coronene molecule in their cavity, while the medium‐size metallarectangles 7 – 9 incorporating 4,4′‐bipyridine linkers are only able to encapsulate anthracene. However, out‐of‐cavity interactions are observed between these 4,4′‐bipyridine‐containing rectangles and pyrene, perylene, or coronene. In contrast, the small pyrazine‐containing metallarectangles 4 – 6 show no interaction in solution with this series of planar aromatic molecules.     

Effect of fluorinated/non‐fluorinated β‐diketones and side‐chain branching of N‐protected amino acids on the antibacterial potential of new heptacoordinated monobutyltin(IV) complexes

The effect of fluorinated/non‐fluorinated β‐diketones and side‐chain branching of N‐protected amino acids on the antibacterial potential of new heptacoordinated monobutyltin(IV) complexes was investigated. New heptacoordinated monobutyltin(IV) complexes having the general formulae BuSn(A)₂B and BuSnA(B)₂ [where AH = (1,3‐dihydro‐1,3‐dioxo‐α‐(substituted)‐2H ‐isoindole‐2‐acetic acids, N‐protected amino acids), R =  CH(CH₃)CH₂CH₃: A₁H; R =  CH(CH₃)₂: A₂H; and BH = R'COCH₂COR″ (β‐diketones), R′ = R″ =  CH₃: B₁H; R′ =  CH₃, R″ =  C₆H₅: B₂H; R′ =  CF₃, R″ =  C₆H₅: B₃H] were synthesized. Complexes BuSn(A)₂B and BuSnA(B)₂ were generated by the reaction of sodium salts of the ligands AH and BH with BuSnCl₃ in 2:1:1 and 1:2:1 molar ratios, respectively. These newly generated complexes were characterized in physicochemical and spectroscopic studies. These complexes contain heptacoordinated tin centres as revealed by ¹¹⁹Sn NMR chemical shift values. Some of the newly generated complexes and their corresponding ligands were screened for their antibacterial activity to study the structure–activity relationship.     

Oxo–Group‐14‐Element Bond Formation in Binuclear Uranium(V) Pacman Complexes

Simple and versatile routes to the functionalization of uranyl‐derived U^V–oxo groups are presented. The oxo‐lithiated, binuclear uranium(V)–oxo complexes [{(py)₃LiOUO}₂(L)] and [{(py)₃LiOUO}(OUOSiMe₃)(L)] were prepared by the direct combination of the uranyl(VI) silylamide “ate” complex [Li(py)₂][(OUO)(N”)₃] (N”=N(SiMe₃)₂) with the polypyrrolic macrocycle H₄L or the mononuclear uranyl (VI) Pacman complex [UO₂(py)(H₂L)], respectively. These oxo‐metalated complexes display distinct U? O single and multiple bonding patterns and an axial/equatorial arrangement of oxo ligands. Their ready availability allows the direct functionalization of the uranyl oxo group leading to the binuclear uranium(V) oxo–stannylated complexes [{(R₃Sn)OUO}₂(L)] (R=nBu, Ph), which represent rare examples of mixed uranium/tin complexes. Also, uranium–oxo‐group exchange occurred in reactions with [TiCl(OiPr)₃] to form U‐O? C bonds [{(py)₃LiOUO}(OUOiPr)(L)] and [(iPrOUO)₂(L)]. Overall, these represent the first family of uranium(V) complexes that are oxo‐functionalised by Group 14 elements.     

Triphenylphosphinopalladium(II) complexes with ONO‐donor ligands: syntheses,structures and catalytic applications in C?C cross‐coupling reactions

Reactions of 1‐((2‐hydroxy‐5‐R‐phenylimino)methyl)naphthalen‐2‐ols (H₂Lⁿ , n  = 1–3 for R = H, Me, Cl, respectively) with [Pd(PPh₃)₂Cl₂] and Et₃N in toluene under reflux produced three new mononuclear square‐planar palladium(II) complexes with the general formula [Pd(Lⁿ )(PPh₃)] ( 1 , R = H; 2 , R = Me; 3 , R = Cl). All the complexes were characterized using elemental analysis, solution conductivity and various spectroscopic (infrared, UV–visible and NMR) measurements. Molecular structures of 1 , 2 , 3 were confirmed using single‐crystal X‐ray diffraction analysis. In each complex, the fused 5,6‐membered chelate rings forming phenolate‐O, azomethine‐N and naphtholate‐O donor (Lⁿ )²⁻ and the PPh₃ form a square‐planar ONOP coordination environment around the metal centre. Infrared and NMR spectroscopic features of 1 , 2 , 3 are consistent with their molecular structures. Electronic spectra of the three complexes display several strong primarily ligand‐centred absorption bands in the range 322–476 nm. All the complexes were found to be effective catalysts for carbon–carbon cross‐coupling reactions of arylboronic acids with aromatic and heteroaromatic aldehydes to form the corresponding diaryl ketones. Copyright © 2016 John Wiley & Sons, Ltd.     

Transfer hydrogenation of ketones catalysed by half‐sandwich (η6‐p‐cymene) ruthenium(II) complexes incorporating benzoylhydrazone ligands

Neutral half‐sandwich η⁶‐p ‐cymene ruthenium(II) complexes of general formula [Ru(η⁶‐p ‐cymene)Cl(L)] (HL = monobasic O, N bidendate benzoylhydrazone ligand) have been synthesized from the reaction of [Ru(η⁶‐p ‐cymene)(μ‐Cl)Cl]₂ with acetophenone benzoylhydrazone ligands. All the complexes have been characterized using analytical and spectroscopic (Fourier transform infrared, UV–visible, ¹H NMR, ¹³C NMR) techniques. The molecular structures of three of the complexes have been determined using single‐crystal X‐ray diffraction, indicating a pseudo‐octahedral geometry around the ruthenium(II) ion. All the ruthenium(II) arene complexes were explored as catalysts for transfer hydrogenation of a wide range of aromatic, cyclic and aliphatic ketones with 2‐propanol using 0.1 mol% catalyst loading, and conversions of up to 100% were obtained. Further, the influence of other variables on the transfer hydrogenation reaction, such as base, temperature, catalyst loading and substrate scope, was also investigated.     

Four novel lanthanide complexes with 4‐ethylbenzoic acid and 5,5′‐dimethy‐2,2′‐bipyridine: Structures,luminescent, thermal properties and bacteriostatic activities

Four new lanthanide complexes [Ln(4‐EBA)₃(5,5′‐DM‐2,2′‐bipy)]₂·2C₂H₅OH (Ln = Ho ( 1 ), Tb ( 2 ), Er ( 3 )); [Ln(4‐EBA)₃(4‐EBAH)(5,5′‐DM‐2,2′‐bipy)]₂ (Ln = Eu( 4 ); 4‐EBA =4‐ethylbenzoate; 5,5′‐DM‐2,2′‐bipy =5,5′‐dimethy‐2,2′‐bipyridine; 4‐EBAH = 4‐ethylbenzoic acid) have been synthesized and characterized by elemental analysis and IR spectra. The single crystal results reveal that complexes 1 – 3 are isostructural. It is worth noting that the mole ratios of the carboxylate ligands and neutral ligands is 4:1 in complex 4 , which is different from the former and has been rarely reported. Nevertheless, all complexes are connected to form 1D chain by π ···π wake staking interactions. Additionally, the complexes 2 (Tb(III)) and 4 (Eu(III)) exhibit characteristic luminescent properties, indicating that ligands can be used as sensitizing chromophore in these systems. The thermal decomposition mechanism of the complexes has been investigated by TG/DSC–FTIR technology. Stacked plots of the FTIR spectra of the evolved gases show complexes broken down into H₂O, CO₂, and other gaseous molecules as well as the gaseous organic fragments. The studies on bacteriostatic activities of complexes show that four complexes have good bacteriostatic activities against Candida albicans but no bacteriostatic activity on Escherichia coli , and Staphylococcus aureus . Additionally, the complexes 1 to 3 have better bacteriostatic activities on Candida albicans than complex 4 .     

Vanadium(III) complexes containing phenoxy–imine–thiophene ligands: Synthesis,characterization and application to homo‐ and copolymerization of ethylene

A set of vanadium(III) complexes, namely {SNO}VCl₂(THF)₂ ( 2a , SNO = thiophene‐(N═CH)‐phenol; 2b , SNO = 5‐phenylthiophene‐(N═CH)‐phenol; 2c , SNO = 5‐phenylthiophene‐(N═CH)‐4‐tert ‐butylphenol; 2d , SNO = 5‐methylthiophene‐(N═CH)‐phenol; 2e , SNO = 5‐methylthiophene‐(N═CH)‐4‐tert ‐butylphenol; 2f , SNO = 5‐methylthiophene‐(N═CH)‐2‐methylphenol; 2g , SNO = 5‐methylthiophene‐(N═CH)‐4‐fluorophenol), were synthesized by reaction of VCl₃(THF)₃ with phenoxy–imine–thiophene proligands ( 1a – g ). All vanadium(III) complexes were characterized using elemental analysis and infrared and electron paramagnetic resonance spectroscopies. Upon activation with methylaluminoxane (MAO), vanadium precatalysts 2a – g proved active in the polymerization of ethylene (213.6–887.2 kg polyethylene (mol[V])⁻¹⋅h⁻¹), yielding high‐density polyethylenes with melting temperatures in the range 133–136 °C and crystallinities varying from 28 to 41%. The 2e/ MAO catalyst system was able to copolymerize ethylene with 1‐hexene affording poly(ethylene‐co ‐1‐hexene)s with melting temperatures varying from 126 to 102 °C and co‐monomer incorporation in the range 3.60–4.00%.     

Dose‐, time‐and lipophilicity‐dependent silver(I)–N‐heterocyclic carbene complexes: Synthesis,characterization and interaction with plasmid and Aedes albopictus DNA

Four new Ag(I)–N‐heterocyclic carbene (NHC) complexes ( 5 – 8 ) bearing symmetrically substituted NHC ligands have been synthesized starting from the corresponding benzimidazolium bromide salts which are accessible in a single step from N ‐substituted benzimidazoles (N ‐alkyl and N ‐aryl) and subsequently reacted with the basic metal source Ag₂O in acetonitrile–methanol. These compounds were characterized using elemental analyses, ¹H NMR, ¹³C NMR, Fourier transform infrared and UV–visible spectroscopic techniques, and molar conductivity. Single‐crystal structural studies for complex 5 show that the Ag(I) centre has a perfectly linear C–Ag–C coordination, with quasi‐parallel pairs of aromatic benzimidazole planes. All the complexes interact with Aedes albopictus DNA via intercalation mode by a large hypochromicity of 22 and 27% and smaller hypochromicity of 16 and 19%. Furthermore, all complexes exhibit efficient DNA cleavage activity via a non‐oxidative mechanistic pathway. The DNase activities of the test compounds revealed a time‐ and concentration‐dependent activity pattern. The Ag(I)–NHC complexes showed considerably higher DNA cleavage activity compared to their respective benzimidazolium salts at a lower concentration. The DNA cleavage of these complexes changed from a moderate effect to a good one, corresponding to the increasing lipophilicity order of the complexes as 5  <  6  <  7  <  8 (1.02, 1.05, 1.78 and 2.06 for 5 – 8 , respectively). This order is further corroborated with the DNA binding study, but with the exception of complex 5 , which shows a better binding ability for DNA (K _b = 3.367 × 10⁶) than complexes 6 – 8 (6.982 × 10⁵, 8.376 × 10⁵ and 1.223 × 10⁶, respectively).     

Organoruthenium (II) complexes featuring pyrazole‐linked Schiff base ligands: Crystal structure,DNA/BSA interactions,cytotoxicity and molecular docking

Half‐sandwiched ruthenium (II) arene complexes with piano stool‐like geometry with the general formula [(p‐cymene)RuClL¹] and [(p‐cymene)RuClL²] [where L¹ = (Z)‐N′‐((1,3‐diphenyl‐1H‐pyrazol‐4‐yl)methylene)furan‐2‐carbohydrazide and L² = (Z)‐N′‐((1,3‐diphenyl‐1H‐pyrazol‐4‐yl)methylene)thiophene‐2‐carbohydrazide] were synthesized and characterized. The single crystal X‐ray data revealed that the complexes belong to the same crystal system (monoclinic) with octahedral geometry, where the ruthenium atom is surrounded by hydrazone ligand coordinated through ON atoms, one chloride labile co‐ligand and the remaining three coordination sites covered by an electron cloud of p‐cymene moiety. The interaction between the complexes and DNA/bovine serum albumin (BSA) was evaluated using absorption and emission titration methods showing intercalative modes of interaction. The DNA cleavage ability of the complexes was checked by agarose gel electrophoresis method exhibiting the destruction of DNA duplex arrangement. To understand the interaction between ruthenium complex and DNA/BSA molecule, molecular docking studies were performed. In vitro cytotoxicity of the complexes was examined by the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay on human lung cancer cell line, A549, and found that at lower IC₅₀, cell growth inhibition has occurred. Similarly, the IC₅₀ values of the complexes treated with cancerous cell lines have produced a significant amount of lactase dehydrogenase and nitrite content in the culture medium, which were evaluated as apoptosis‐inducing factors, suggesting that the ruthenium (II) arene hydrazone complexes with pyrazole ligands have promising anticancer activities.     

Spectroscopic and electrochemical study for evaluating DNA interaction activity of 4‐(3‐halophenyl)‐6‐(pyridin‐2‐yl)pyrimidin‐2‐amine based piano stool Cp* Rh (III) and Ir (III) complexes

Six novel organometallic half sandwich complexes [(η5‐C₅Me₅)M(L^1–3)Cl]Cl.2H₂O were synthesized using [{(η⁵‐C₅Me₅)M(μ‐Cl)Cl₂], where M = Ir (III)/Rh (III) and L^1–3 = three pyridyl pyrimidine based ligands; and characterized by NMR, Infra‐red spectroscopy, conductance, elemental and thermal analysis. The complex‐DNA binding mode and/or strength evaluated using absorption titration, electrochemical studies and hydrodynamic measurement proposed intercalative binding mode, which was also confirmed by molecular docking study. Differential pulse voltammetry and cyclic voltammetry studies indicated an alteration in oxidation and reduction potentials of complexes (M⁺⁴/M⁺³) in presence of CT‐DNA. The metal complexes can cleave plasmid DNA as proposed in gel electrophoretic analysis. The LC₅₀ values of complexes evaluated on brine shrimp suggested their potent cytotoxic nature.     

Ruthenium–Arene–β‐Carboline Complexes as Potent Inhibitors of Cyclin‐Dependent Kinase 1: Synthesis,Characterization and Anticancer Mechanism Studies

A series of Ru^II–arene complexes ( 1 – 6 ) of the general formula [(η⁶‐arene)Ru(L)Cl]PF₆ (arene=benzene or p‐cymene; L=bidentate β‐carboline derivative, an indole alkaloid with potential cyclin‐dependent kinases (CDKs) inhibitory activities) is reported. All the complexes were fully characterized by classical analytical methods, and three were characterized by X‐ray crystallography. Hydrolytic studies show that β‐carboline ligands play a vital role in their aqueous behaviour. These complexes are highly active in vitro, with the most active complex 6 displaying a 3‐ to 12‐fold higher anticancer activity than cisplatin against several cancer cell lines. Interestingly, the complexes are able to overcome cross‐resistance to cisplatin, and show much lower cytotoxicity against normal cells. Complexes 1 – 6 may directly target CDK1, because they can block cells in the G2M phase, down‐regulate the expression of CDK1 and cyclin B1, and inhibit CDK1/cyclin B in vitro. Further mechanism studies show that the complexes can effectively induce apoptosis through mitochondrial‐related pathways and intracellular reactive oxygen species (ROS) elevation.     

2D l‐Di‐toluoyl‐tartaric acid Lanthanide Coordination Polymers: Toward Single‐component White‐Light and NIR Luminescent Materials

A series of five l ‐di‐p‐toluoyl‐tartaric acid (l ‐DTTA) lanthanide coordination polymers, namely {[Ln₄K⁴ L₆(H₂O)_x]?yH₂O}_n, [Ln=Dy ( 1 ), x=24, y=12; Ln=Ho ( 2 ), x=23, y=12; Ln=Er ( 3 ), x=24, y=12; Ln=Yb ( 4 ), x=24, y=11; Ln=Lu ( 5 ), x=24, y=12] have been isolated by simple reactions of H₂L (H₂L= L ‐DTTA) with LnCl₃?6 H₂O at ambient temperature. X‐ray crystallographic analysis reveals that complexes 1 – 5 feature two‐dimensional (2D) network structures in which the Ln³⁺ ions are bridged by carboxylate groups of ligands in two unique coordinated modes. Luminescent spectra demonstrate that complex 1 realizes single‐component white‐light emission, while complexes 2 – 4 exhibit a characteristic near‐infrared (NIR) luminescence in the solid state at room temperature.     

Synthesis and structure of para‐toluene sulfonamide lanthanide complexes and their application in the polymerization of ε‐caprolactone

A series of para‐toluene sulfonamide ligands [TsNHPr‐i( HL ₁ ), TsNHBu‐t( HL ₂ ), TsNHPh( HL ₃ ), TsNHPhMe‐p( HL ₄ ), TsNHPhOMe‐p( HL ₅ )] were synthesized by amidation using para‐toluene sulfonyl chloride reacting with different primary amines. A series of homoleptic lanthanide complexes (Ln L₃, 1–10) (Ln = La, L = L₁ ( 1 ), Ln = Gd, L = L₂ ( 2 ), Ln = La, L = L₂ ( 3 ), Ln = Gd, L = L₂( 4 ), Ln = La, L = L₃ ( 5 ), Ln = Gd, L = L₃ ( 6 ), Ln = La, L = L₄ ( 7 ), Ln = Gd, L = L₄( 8 ), Ln = La, L = L₅ ( 9 ), Ln = Gd, L = L₅ ( 10 )) were prepared by amine elimination reactions of the ligands with Ln[N(SiMe₃)₂]₃ (Ln = La, Gd). Complexes 1 , 3 , 5 , 7 and 9 were all characterized by NMR spectra, and the structures of complex 3 was determined by single‐crystal X‐ray diffraction. Complex 3 crystallizes a binuclear cluster, consisting of two La³⁺ and six (TsNBu‐t)⁻ anions. Three (TsNBu‐t)⁻ anions are chelating to each La³⁺ as bidentate model with O and N forming three‐membered chelate rings; one of three anions is bridging to another La³⁺ via oxygen. All complexes were characterized using elemental analysis and infrared spectra. The catalytic properties of complexes 1–10 for the ring‐opening polymerization of ε‐caprolactone were studied and the results showed that all complexes are efficient initiators for this ring‐opening polymerization reaction.     

Ligand Substitution Reactions on Aquapentachloro‐ and Hexachloroplatinic Acid — Synthesis and Characterization of Tetrachloroplatinum(IV) Complexes with Heterocyclic N,N Donors

Reactions of aquapentachloroplatinic acid, (H₃O)[PtCl₅(H₂O)]·2(18C6)·6H₂O ( 1 ) (18C6 = 18‐crown‐6), and H₂[PtCl₆]·6H₂O ( 2 ) with heterocyclic N, N donors (2, 2′‐bipyridine, bpy; 4, 4′‐di‐tert‐butyl‐2, 2′‐bipyridine, tBu₂bpy; 1, 10‐phenanthroline, phen; 4, 7‐diphenyl‐1, 10‐phenanthroline, Ph₂phen; 2, 2′‐bipyrimidine, bpym) afforded with ligand substitution platinum(IV) complexes [PtCl₄(N∩N)] (N∩N = bpy, 3a ; tBu₂bpy, 3b ; Ph₂phen, 5 ; bpym, 7 ) and/or with protonation of N, N donor yielding (R₂phenH)₂[PtCl₆] (R = H, 4a ; Ph, 4b ) and (bpymH)⁺ ( 8 ). With UV irradiation Ph₂phen and bpym reacted with reduction yielding platinum(II) complexes [PtCl₂(N∩N)] (N∩N = Ph₂phen, 6 ; bpym, 9 ). Identities of all complexes were established by microanalysis as well as by NMR (¹H, ¹³C, ¹⁹⁵Pt) and IR spectroscopic investigations. Molecular structures of [PtCl₄(bpym)]·MeOH ( 7 ) and [PtCl₂(Ph₂phen)] ( 6 ) were determined by X‐ray diffraction analyses. Differences in reactivity of bpy/bpym and phen ligands are discussed in terms of calculated structures of complexes [PtCl₅(N∩N)]^— with monodentately bound N, N ligands (N∩N = bpy, 10a ; phen, 10b ; bpym, 10c ).     

Pd‐Iminocarboxylate Complexes and Their Behavior in Ethylene Polymerization

Designing co‐catalyst‐free late transition metal complexes for ethylene polymerization is a challenging task at the interface of organometallic and polymer chemistry. Herein, a set of new, co‐catalyst‐free, single‐component catalytic systems for ethylene polymerization have been unraveled. Treatment of anthranilic acid with various aldehydes produced four iminocarboxylate ligands ( L1 – L4 ) in very good to excellent yield (75–92 %). The existence of 2‐((2‐methoxybenzylidene)amino) benzoic acid ( L1 ) has been unambiguously demonstrated using NMR spectroscopy, MS and single‐crystal X‐ray diffraction. A neutral Pd‐iminocarboxylate complex [{N O}PdMe(L1)] (N O=κ²‐N,O‐ArCHNC₆H₄CO₂ with Ar=2‐MeOC₆H₄) C1 was prepared by treating stoichiometric amount of L1.Na with palladium precursor. The identity of C1 was confirmed by 1–2D NMR spectroscopy and single‐crystal X‐ray diffraction studies. Along the same lines, palladium complexes C2 – C4 were prepared from ligands L2 – L4 respectively. In‐situ high‐pressure NMR investigations revealed that these Pd complexes are amenable to ethylene insertion and undergo facile β‐H elimination to produce propylene. These palladium complexes were then evaluated in ethylene polymerization reaction and various reaction parameters were screened. When C1 – C4 were exposed to ethylene pressures of 10–50 bar, formation of low‐molecular‐weight polyethylene was observed.     

Cyano‐Bridged ‘Oximato’ Complexes: Synthesis,Structure, and Catalase‐Like Activities

The reaction of the ‘oximato’‐ligand precursor A (Fig. 1) and metal salts with KCN gave two mononuclear complexes [ML(CN)(H₂O)_n](ClO₄) ( 1 and 2 ; L={N‐(hydroxy‐κO)‐α‐oxo‐N′‐[(pyridin‐2‐yl‐κN)methyl[1,1′‐biphenyl]‐4‐ethanimidamidato‐κN′}; M=Co^II ( 1 ), Cu^II ( 2 ); n=2 for Co^II, n=0 for Cu^II; Figs. 2 and 3). The new cyano‐bridged pentanuclear ‘oximato’ complexes [{ML(H₂O)_n(NC)}₄M¹(H₂O)_x](ClO₄)₂ ( 3 – 6 ) and trinuclear complexes [{ML(H₂O)_n(NC)}₂M¹L](ClO₄) ( 7 – 10 ) ([M¹=Mn^II, Cu^II; x=2 for Mn^II, x=0 for Cu^II] were synthesized from mononuclear complexes and characterized by elemental analyses, magnetic susceptibility, molar conductance, and IR and thermal analysis. The four [ML(CN)(H₂O)_n]⁺ moieties are connected by a metal(II) ion in the pentanuclear complexe 3 – 6 , each one involving four cyano bridging ligands (Fig. 4). The central metal ion displays a square‐planar or octahedral geometry, with the cyano bridging ligands forming the equatorial plane. The axial positions are occupied by two aqua ligands in the case of the central Mn‐atom. The two [ML(CN)(H₂O)_n]⁺ moieties and an ‘oximato’ ligand are connected by a metal(II) ion in the trinuclear complexes 7 – 10 , each one involving two cyano bridging ligands (Fig. 5). The central metal ions display a distorted square‐pyramidal geometry, with two cyano bridging ligands and the donor atoms of the tridentate ‘oximato’ ligand. Moreover catalytic activities of the complexes for the disproportionation of hydrogen peroxide (H₂O₂) were also investigated in the presence of 1H‐imidazole. The synthesized homopolynuclear Cu^II complexes 6 and 10 displayed eficiency in disproportion reactions of H₂O₂ producing H₂O and dioxygen thus showing catalase‐like activity.     

Tweaking the affinity of aryl‐substituted diazosalicylato‐ and pyridine ligands towards Zn (II) and its neighbors in the periodic system of the elements,Cu (II) and Cd (II), and their antimicrobial activity

A series of six new Zn (II) compounds, viz., [Zn(HL^ASA)₂(Py)₂] ( 1 ), [Zn(HL^MASA)₂(Py)₂] ( 2 ), [Zn(HL^MASA)₂(4‐MePy)₂] ( 3 ), [Zn(HL^CASA)₂(4‐MePy)₂] ( 4 ), [Zn(HL^BASA)₂(Py)₂] ( 5 ), [Zn(HL^BASA)₂(4‐MePy)₂] ( 6 ) and representative Cu (II) and Cd (II) complexes, viz., [Cu(HL^ASA)₂(Py)₂(H₂O)] ( 7 ) and [Cd(HL^BASA)₂(Py)₃] ( 8 ) [(HL^XASA)^? = para‐substituted 5‐[(E)‐2‐(aryl)‐1‐diazenyl]‐2‐hydroxybenzoate with X = H (ASA), Me (MASA), Cl (CASA) or Br (BASA); Py = pyridine; 4‐MePy = 4‐methylpyridine] have been synthesized and characterized by spectroscopic techniques and single‐crystal X‐ray diffraction analysis. The structural characterization of the compounds revealed distorted tetrahedral ( 1 – 6 ), square‐pyramidal ( 7 ) and pentagonal‐bipyramidal ( 8 ) coordination geometries around the metal atom, in which the aryl‐substituted diazosalicylate ligands are coordinated only through the oxygen atoms of carboxylate groups, either in an anisobidentate or isobidentate mode; meanwhile, the 2‐hydroxy groups of the monoanionic ligand (HL^XASA)^? are involved only in intramolecular O‐H···O hydrogen bonds with the carboxylate function. In the crystal structures of 1 – 8 , the complex molecules are assembled by π‐stacking interactions giving mostly infinite 1D strands. The intermolecular binding in the solid state structures is accomplished by diverse additional non‐covalent contacts including C‐H···O, C‐H···N, C‐H···π, C‐H···Br, O···Br, Br···π and van der Waals contacts. Although the primary and secondary ligands in the Zn (II) complex series 1 – 6 carry different substituents at the periphery (X = H, Me, Cl, Br for (HL^XASA)^? and R = H, Me for 4‐Py‐R), five of the crystal structures were isostructural. Additionally, the antimicrobial activity of the pro‐ligands H₂L^XASA and their Zn (II), Cu (II) and Cd (II) compounds were studied in a comparative manner, showing high sensitivity (IZD ≥ 20) against Bacillus subtilis.